DAVID SZUSTER: Open Payments
NPI 1083721245 · JACKSON HEIGHTS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,031 in 99 payments from 11 companies in 2025. Trend: 2023 $1,885 · 2024 $2,930 · 2025 $3,031
Food & beverage: $3,031
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $788 |
| Teva Pharmaceuticals USA, Inc. | 18 | $517 |
| Alkermes, Inc. | 11 | $423 |
| Otsuka America Pharmaceutical, Inc. | 11 | $307 |
| Janssen Pharmaceuticals, Inc | 7 | $251 |
| ABBVIE INC. | 9 | $245 |
| Lundbeck LLC | 8 | $209 |
| E.R. Squibb & Sons, L.L.C. | 5 | $175 |
| Axsome Therapeutics, Inc. | 2 | $61 |
| Corium, LLC | 1 | $31 |
Products named: CAPLYTA, UZEDY, VRAYLAR, ARISTADA, ABILIFY MAINTENA, SPRAVATO, LYBALVI, REXULTI.
Industry payments across NY — which companies pay providers there.
